<?xml version="1.0" encoding="ISO-8859-1" ?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>PR.com Press Releases: Genomic Nanosystems News</title>
		<link>http://www.PR.com/</link>
		<description>Latest news releases from PR.com for Genomic Nanosystems.</description>
		<lastBuildDate>Tue, 14 Feb 2012 18:27:37 -0500</lastBuildDate>
		<copyright>&#169; 2012 PR Worldwide, Inc.</copyright>
		<ttl>60</ttl>
		<language>en-us</language>
		<image>
			<url>http://www.PR.com/images/logo_white.jpg</url>
			<title>PR.com Press Releases: Genomic Nanosystems News</title>
			<link>http://www.PR.com/</link>
			<width>68</width>
			<height>69</height>
			<description>PR.com provides Free Press Release Distribution, &amp; is a unique Directory of Businesses, Products, Services, &amp; Jobs - in all industries.  Find Full Company Profiles.</description>
		</image>
		<atom:link href="http://www.pr.com/rss/press-releases-2/53053.xml" rel="self" type="application/rss+xml" />
		<item>
			<guid isPermaLink="true">http://www.pr.com/press-release/106919</guid>
			<title>Genomic Nanosystems Announces Exclusive Licensing Agreement to Sequenom for the Right to Use Digital PCR in Prenatal Testing and Mass Spectrometry</title>
			<pubDate>Mon, 22 Sep 2008 11:57:00 -0400</pubDate>
			<description>Genomic Nanosystems, LLC, today announced that it has granted an exclusive license to Sequenom, Inc. (Nasdaq: SQNM) for the right to use Digital PCR in noninvasive prenatal research and diagnostics on a technology, platform and sample independent basis, and has granted the exclusive right to use digital PCR in conjunction with mass spectrometry for any diagnostic or research purpose, excluding second generation genetic [PR.com]</description>
			<link>http://www.pr.com/press-release/106919</link>
			<dc:creator>Genomic Nanosystems</dc:creator>
		</item>
		<item>
			<guid isPermaLink="true">http://www.pr.com/press-release/87956</guid>
			<title>Genomic Nanosystems Announced Today That It Has Received the Exclusive Patent Rights for Clonal Amplification and Digital PCR (Polymerase Chain Reaction) from Cytonix</title>
			<pubDate>Sun, 01 Jun 2008 03:00:00 -0400</pubDate>
			<description>Genomic Nanosystems, LLC has received the exclusive patent rights to U.S. patent No. 6,143,496. Patent &#8216;496 was first to describe methods for detecting single nucleic acid molecules after one amplification step, for amplifying one or more nucleic acids in nano-scale volumes or regions, and for carrying out digital PCR. [PR.com]</description>
			<link>http://www.pr.com/press-release/87956</link>
			<dc:creator>Genomic Nanosystems</dc:creator>
		</item>
	</channel>
</rss>
